A local company has agreed to occupy about 160,000 square feet of the city’s latest biotech lab space complex — 101 College Street — which hasn’t even been built yet.

Officials with Arvinas announced Tuesday the company has signed a 10 year-lease for three of the 10 floors in the building, or about one-third of the space in the 500,000-square foot-building. Massachusetts-based Winstanley Enterprises is developing the multi-tenant project, with construction scheduled to get underway by the end of June, according to company officials.

Arvinas was founded by Craig Crews, a professor of molecular, cellular and developmental biology at Yale University. The company’s focus is developing treatments for cancers and other difficult-to-treat diseases. Read More

Get ready for things to start happening at Tweed New Haven Regional Airport.

And stay tuned; there may be more on the way, according to federal documents Hearst Connecticut Newspapers has obtained.

Look this summer for new commercial service at Tweed by startup airline Avelo Airlines — the first new American mainline airline in nearly 15 years — which wants to make New Haven a “focus city” for its East Coast operations, company, Tweed and government officials plan to announce later today.

Get ready for a longer runway — 1,035 feet longer, up from the current 5,600 feet to 6,635 feet, as approved earlier this year in Tweed’s 20-year master plan update. Read More

New Haven entered a new phase of the Covid-19 pandemic: Cases are way down. Plenty of vaccine is available. But it now looks like the coronavirus is here to stay.

Yale New Haven Health officials detailed that new phase Monday in an online press briefing.

They spoke as The New York Times reported that vaccine hesitancy has convinced public health experts that society will not reach the 80 percent “herd immunity” necessary to eliminate Covid-19.

YNHH Chief Clinical Officer Tom Balcezak and CEO Marna Borgstrom agreed with that assessment.

Balcezak noted that humankind has succeeded in eradicating only one infectious disease, smallpox. Given vaccine hesitancy and the lack of vaccines in nations with new outbreaks (and variants), Covid-19 is not looking like it will become the second. Read More

For decades, manufacturers in the U.S. have warned of a massive skills gap: There just aren't enough new skilled workers to make up for older ones who are retiring. In this installment of our series, "Roads to Recovery," NewsHour Weekend’s Christopher Booker reports from Connecticut on how the pandemic has accelerated a push to improve and expand job training for the state's large manufacturing workforce. Read More

More than 70% of all adults have received the first dose of the COVID-19 vaccine in Connecticut, becoming the first state in the U.S. to reach this benchmark.

Governor Ned Lamont announced on Twitter that over 70% of people 18 and up have received their first dose.

The governor said Connecticut is nearly two months ahead of the president's national goal. Read More